Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1068 | 960 | 1109 | 1150 | 1383 | 1741 |
Fund Return | 6.78% | -4.03% | 10.88% | 4.75% | 6.69% | 5.7% |
Place in category | 1321 | 1507 | 1267 | 819 | 654 | 487 |
% in Category | 62 | 72 | 61 | 47 | 43 | 50 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global SmartBeta Equity ZI Capitale | 1.97B | 24.99 | 10.30 | 11.79 | ||
LU1774149998 | 1.97B | 24.59 | 9.91 | 11.40 | ||
LU1536921650 | 1.01B | 18.26 | 0.25 | - | ||
Global Optimal Income E Capitalisat | 650.2M | 12.11 | -0.36 | 2.94 | ||
Global Optimal Income F Capitalisat | 650.2M | 13.25 | 0.74 | 4.09 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Growth Fund Y DIST EUR | 63.75M | 17.95 | 7.47 | 6.51 | ||
European Growth Fund A DIST Eue | 6.48B | 17.06 | 6.55 | 5.62 | ||
European Growth Fund A Acc EUR | 156.67M | 17.05 | 6.54 | 5.62 | ||
European Growth Fund E Acc EUR | 20.34M | 16.23 | 5.74 | 4.83 | ||
European Growth Fund Y Acc EUR | 248.03M | 17.90 | 7.45 | 6.50 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 4.80 | 10,412.0 | +1.52% | |
ASML Holding | NL0010273215 | 4.69 | 683.90 | -0.32% | |
Allianz | DE0008404005 | 4.28 | 294.25 | -0.12% | |
Ashtead Group | GB0000536739 | 3.29 | 4,950.0 | -1.59% | |
Novo Nordisk B | DK0062498333 | 3.08 | 622.6 | +5.67% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review